Wilson Sonsini Goodrich & Rosati advised Highland Electric Transportation on the deal. The Board of Education in Maryland’s Montgomery County voted unanimously to approve a 16-year,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Simplify Medical on the deal. NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Perrone Robotics on the deal. CapStone Holdings, a business incubator and investment group, announced a $10 million equity investment in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Plume on the deal. Plume, a software-as-a-service platform for communications service providers, announced the close of a $270 million minority...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Lilly Asia Ventures on the deal. Regor Therapeutics, a clinical-stage biotechnology company dedicated to the discovery of innovative medicines to...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosat advised Spire Global, Inc. on the deal. Spire Global, Inc., a global provider of space-based data and analytics, and NavSight Holdings...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Vividion Therapeutics, Inc. and the lead investors on the deal. Vividion Therapeutics, Inc., a biotechnology company utilizing novel discovery technologies...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati and Taylor Wessing advised WuXi AppTec on the deal. WuXi AppTec, a leading global provider of R&D- and manufacturing-enabling services in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Modern Health on the deal. Modern Health, the mental health and wellness platform supporting over 220 enterprises globally, announced that...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ally.io on the deal. Ally.io, a high-growth technology company specializing in goal-setting and business execution software, or objective and key...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Day One Biopharmaceuticals on the deal. Day One Biopharmaceuticals, a clinical-stage biopharmaceutical company focused on accelerating new, promising targeted therapies...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Excision BioTherapeutics on the deal. Excision BioTherapeutics, a leading developer of potentially curative CRISPR anti-viral therapies to improve patient lives,...
You must be a Standard 1 Year member to access this content.
